Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum
MDRTB01
Genome Sequencing of MDR TB in Sputum
1 other identifier
observational
50
1 country
1
Brief Summary
Drug resistant tuberculosis is a growing problem world wide. The current methods for diagnosis are time consuming and may delay diagnosis and treatment for many weeks. In this study the investigators wish to take sputum samples from patients to see if the investigators can validate a molecular DNA based process for prompt identification of drug resistant tuberculosis. The investigators wish to extract and amplify DNA from drug resistant tuberculosis and identify genes within it that confer resistance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedFirst Submitted
Initial submission to the registry
September 12, 2014
CompletedFirst Posted
Study publicly available on registry
September 19, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedSeptember 19, 2014
September 1, 2014
3 years
September 12, 2014
September 17, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Identification and sequencing of mycobacterial DNA from sputum samples
To see if mycobacterial DNA can be identified and sequenced from sputum and if the results correlate with the Microtiter Plate Methods done phenotypically in the standard manner.
within 24 hours of sample collection
Study Arms (1)
Patients with expected MDR TB
Eligibility Criteria
Smear positive patients with confirmed or suspected TB
You may qualify if:
- Any patient with smear positive tuberculosis who is capable to give informed consent will be offered to be included in the trial.
You may not qualify if:
- Any patient under 18 or who is unable to give informed consent will be excluded from this trial. Any patient who is unable to give a sputum sample.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St George's NHS Healthcare Trust
London, SW180RE, United Kingdom
Biospecimen
Sputum samples
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 12, 2014
First Posted
September 19, 2014
Study Start
April 1, 2013
Primary Completion
April 1, 2016
Last Updated
September 19, 2014
Record last verified: 2014-09